Jumping translocation breakpoint (JTB), also known as the prostate androgen receptor (PAR), was described as a transmembrane protein gene at 1q21 rearranged in an jumping translocation (JT)—a rare chromosome aberration involved in various types of cancers, including BC [2,3,4]. Here, JTB is linked to breast cancer.